NasdaqGS - Delayed Quote • USD
Schrödinger, Inc. (SDGR)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:29 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 7 | 9 | 8 |
| Avg. Estimate | -0.75 | -0.82 | -2.79 | -2.46 |
| Low Estimate | -0.86 | -0.91 | -3.11 | -3.08 |
| High Estimate | -0.64 | -0.75 | -2.34 | -1.83 |
| Year Ago EPS | 1.75 | 0.06 | 0.54 | -2.79 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 8 | 10 | 9 |
| Avg. Estimate | 41.97M | 40.72M | 206.67M | 288.92M |
| Low Estimate | 39.32M | 36.52M | 200.88M | 219.17M |
| High Estimate | 45.4M | 48.2M | 212.12M | 440.1M |
| Year Ago Sales | 64.78M | 37.87M | 216.67M | 206.67M |
| Sales Growth (year/est) | -35.20% | 7.50% | -4.60% | 39.80% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 1.31 | -0.47 | -0.71 | -0.38 |
| EPS Actual | 1.75 | 0.06 | -0.86 | -0.41 |
| Difference | 0.44 | 0.53 | -0.15 | -0.03 |
| Surprise % | 33.60% | 112.80% | -21.10% | -7.90% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.75 | -0.82 | -2.79 | -2.46 |
| 7 Days Ago | -0.76 | -0.82 | -2.8 | -2.46 |
| 30 Days Ago | -0.76 | -0.82 | -2.8 | -2.46 |
| 60 Days Ago | -0.67 | -0.72 | -2.3 | -1.65 |
| 90 Days Ago | -0.67 | -0.72 | -2.27 | -1.65 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | 1 | -- |
Growth Estimates
| CURRENCY IN USD | SDGR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -142.90% | -- | -- | 5.40% |
| Next Qtr. | -1,466.70% | -- | -- | 10.90% |
| Current Year | -616.70% | -- | -- | 4.50% |
| Next Year | 11.80% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -4.30% | -- | -- | 10.94% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Citigroup: Buy to Buy | 3/1/2024 |
| Maintains | Goldman Sachs: Neutral to Neutral | 3/1/2024 |
| Maintains | Keybanc: Overweight to Overweight | 2/29/2024 |
| Maintains | Citigroup: Buy to Buy | 2/29/2024 |
| Maintains | B of A Securities: Neutral to Neutral | 2/29/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 2/29/2024 |
Related Tickers
CERT Certara, Inc.
16.57
+1.66%
TDOC Teladoc Health, Inc.
13.01
-2.40%
TXG 10x Genomics, Inc.
27.59
+2.57%
ACCD Accolade, Inc.
7.89
-14.15%
GDRX GoodRx Holdings, Inc.
7.19
+1.55%
DOCS Doximity, Inc.
23.82
+0.97%
VEEV Veeva Systems Inc.
200.91
+0.91%
PGNY Progyny, Inc.
32.04
-1.42%
GEHC GE HealthCare Technologies Inc.
86.24
+0.34%
LFMD LifeMD, Inc.
11.95
+10.44%